OCTEL CORP
10-Q, EX-27, 2000-11-09
CHEMICALS & ALLIED PRODUCTS
Previous: OCTEL CORP, 10-Q, 2000-11-09
Next: GENETRONICS BIOMEDICAL LTD, 10-Q, 2000-11-09



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS, STATEMENTS OF INCOME, AND STATEMENTS OF CASH FLOWS
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          41,400
<SECURITIES>                                         0
<RECEIVABLES>                                   86,200
<ALLOWANCES>                                     2,300
<INVENTORY>                                     58,600
<CURRENT-ASSETS>                               187,400
<PP&E>                                         111,300
<DEPRECIATION>                                  26,100
<TOTAL-ASSETS>                                 709,800
<CURRENT-LIABILITIES>                          125,200
<BONDS>                                        205,000
                                0
                                          0
<COMMON>                                           100
<OTHER-SE>                                     286,400
<TOTAL-LIABILITY-AND-EQUITY>                   709,800
<SALES>                                        303,400
<TOTAL-REVENUES>                               306,800
<CGS>                                          182,400
<TOTAL-COSTS>                                  263,600
<OTHER-EXPENSES>                                18,500
<LOSS-PROVISION>                                   100
<INTEREST-EXPENSE>                              18,500
<INCOME-PRETAX>                                 22,600
<INCOME-TAX>                                    11,300
<INCOME-CONTINUING>                             11,300
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,300
<EPS-BASIC>                                       0.88
<EPS-DILUTED>                                     0.86


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission